Other researchers generated AXL-redirected CAR-Ts with a constitutively activated IL-7 receptor (C7R); they demonstrated a significant tumor cell killing capacity, which was more efficacious than by using conventional AXL-redirected CAR-Ts, in TNBC MDA-MB-231 and MDA-MB-468 cell lines. This evidence concerns the gene AXL and neoplasm.